• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.13% Nasdaq Up0.57%

    Sinovac Biotech Ltd. (SVA)

    -NasdaqGS
    5.25 Up 0.35(7.14%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 63,101   72,524   49,216  
    Cost of Revenue16,493  21,273  19,100  
    Gross Profit 46,608   51,251   30,116  
    Operating Expenses
    Research Development11,034  8,384  17,044  
    Selling General and Administrative34,683  34,538  32,907  
    Non Recurring403  (416)1,316  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 488   8,745   (21,151)
    Income from Continuing Operations
    Total Other Income/Expenses Net4,041  2,431  2,293  
    Earnings Before Interest And Taxes4,529  11,176  (18,858)
    Interest Expense3,407  3,031  775  
    Income Before Tax1,122  8,145  (19,633)
    Income Tax Expense1,458  (2,225)(884)
    Minority Interest(515)(2,928)3,896  
    Net Income From Continuing Ops(851)7,442  (14,853)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (851) 7,442   (14,853)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (851) 7,442   (14,853)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.